Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jan 28, 2007 at 9:19 PM EST

Some Thoughts On JNJ and Abbott Labs

By Vitaliy Katsenelson, CFA January 26, 2007 It seems that 2007 should be a brighter year for Johnson &…

Douglas A. McIntyre | Jan 28, 2007 at 9:16 PM EST

Friday’s Top Biotech and Medical Stocks

Biotechnology FERMAVIR PHARMACEUTL [FMVR.OB] +19.05% POLYMEDIX INC [PYMX.OB] +14.29% KOSAN BIOSCIENCES [KOSN] +11.11% BIONOVO INC [BNVI.OB] +10.04% NEURO-HITECH INC [NHPI.OB]…

Douglas A. McIntyre | Jan 28, 2007 at 9:14 PM EST

IBD Weekly Top Ranked Medical Stocks

The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s…

Douglas A. McIntyre | Jan 28, 2007 at 9:08 PM EST

Three Biotech Drugs Have Potential to Treat Polonium-210 Radiation

by H.S. AyoubBioHealth Investor.com After the murder of former Russian intelligence agent Alexander Litvinenko government agencies began to worry about…

Douglas A. McIntyre | Jan 26, 2007 at 3:55 AM EST

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology FERMAVIR PHARMACEUTL [FMVR.OB] +17.60% OBAGI MEDICAL [OMPI] +8.72% XTL BIOPHARMACEUTICA [XTLB] +7.31% CYTORI THERAPEUTICS [CYTX] +7.16%…

Douglas A. McIntyre | Jan 26, 2007 at 3:53 AM EST

Why Does Proctor & Gamble Need a Dental Laser?

From BioHealth Investor by H.S. AyoubBioHealth Investor.com BioLase Technology (BLTI) announced early Thursday that the company had signed a definitive…

Douglas A. McIntyre | Jan 25, 2007 at 4:12 PM EST

Amgen Treated Like a Normal Drug Stock

Amgen (AMGN-NASDAQ) posted EPS of $0.90, but $0.71 on GAAP EPS. Revenues were $3.73 Billion versus $3.7 Billion estimates. Revenues…

Douglas A. McIntyre | Jan 25, 2007 at 4:18 AM EST

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology NEUROBIOLOGICAL TECH [NTII] +8.26% INTROGEN THERAPEU [INGN] +7.89% CYTRX CP [CYTR] +7.86% IMMUNE RESPONSE CORP [IMRP.OB]…

Douglas A. McIntyre | Jan 25, 2007 at 4:17 AM EST

Expert Panel Urges Change to Birth Control Pill Studies

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Many would be surprised to learn that obese women are excluded from birth…

Douglas A. McIntyre | Jan 23, 2007 at 9:03 PM EST

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology POLYMEDIX INC [PYMX.OB] +16.67% NUTRITION 21 INC [NXXI] +13.76% CYTRX CP [CYTR] +11.17% CORCEPT THERAPEUTICS [CORT]…

Douglas A. McIntyre | Jan 23, 2007 at 2:16 PM EST

Novavax to Advance Avian Flu Vaccine Despite Government Snub

From BioHealth Investor Shares of Novavax, Inc. (NVAX) shot up almost 10% in after hours trading on Monday as the…

Douglas A. McIntyre | Jan 23, 2007 at 2:15 PM EST

Monday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology HALOZYME THERAPEUTIC [HTI] +9.87% XTL BIOPHARMACEUTICA [XTLB] +9.02% HEMOBIOTECH INC [HMBT.OB] +8.50% NOVACEA, INC. [NOVC] +7.46%…

Douglas A. McIntyre | Jan 23, 2007 at 5:48 AM EST

Pfizer Should Buy Teva

As Big Pharma companies lose share to generics, Wall St.’s theory is that they should buy smaller companies that are…

Douglas A. McIntyre | Jan 22, 2007 at 4:49 AM EST

Friday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology VANDA PHARMACEUTICAL [VNDA] +10.30% EMERGENT BIOSOLUTION [EBS] +9.20% BOSTON LIFE SCIENCES [BLSI] +8.03% LEV PHARMACEUTICALS [LEVP.OB]…

Douglas A. McIntyre | Jan 22, 2007 at 4:47 AM EST

IBD Weekly Top Ranked Medical Stocks

From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative…

1 … 383 384 385 386 387 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Some Thoughts On JNJ and Abbott Labs

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

Three Biotech Drugs Have Potential to Treat Polonium-210 Radiation

Thursday’s Top Biotech and Medical Stocks

Why Does Proctor & Gamble Need a Dental Laser?

Amgen Treated Like a Normal Drug Stock

Wednesday’s Top Biotech and Medical Stocks

Expert Panel Urges Change to Birth Control Pill Studies

Tuesday’s Top Biotech and Medical Stocks

Novavax to Advance Avian Flu Vaccine Despite Government Snub

Monday’s Top Biotech and Medical Stocks

Pfizer Should Buy Teva

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Health and Healthcare Articles

All Health and Healthcare Articles

Some Thoughts On JNJ and Abbott Labs

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

Three Biotech Drugs Have Potential to Treat Polonium-210 Radiation

Thursday’s Top Biotech and Medical Stocks

Why Does Proctor & Gamble Need a Dental Laser?

Amgen Treated Like a Normal Drug Stock

Wednesday’s Top Biotech and Medical Stocks

Expert Panel Urges Change to Birth Control Pill Studies

Tuesday’s Top Biotech and Medical Stocks

Novavax to Advance Avian Flu Vaccine Despite Government Snub

Monday’s Top Biotech and Medical Stocks

Pfizer Should Buy Teva

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s